- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT Chemical synthesis was used to prepare the HIV-1 protease specifically 13C-labelled in the catalytically essential Asp 25 in each monomer. The NMR chemical shift of the 13C-enriched
homodimeric enzyme was measured in the presence of the inhibitor pepstatin, a mimic of the tetrahedral intermediate formed in enzyme catalysis. In this complex, the catalytic carboxyls do
not titrate in the pH range where the enzyme is active; throughout the range pH 2.5–6.5, one Asp 25 side chain is protonated and the other deprotonated. By contrast, in the absence of
inhibitor the two Asp side chains are chemically equivalent and both deprotonated at pH 6, the optimum for enzymatic activity. These direct observations of the chemical properties of the
catalytic apparatus of the enzyme provide concrete information on which to base the design of improved HIV-1 protease inhibitors. Access through your institution Buy or subscribe This is a
preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per
year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated
during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS AUTOPROCESSING
AND OXYANION LOOP REORGANIZATION UPON GC373 AND NIRMATRELVIR BINDING OF MONOMERIC SARS-COV-2 MAIN PROTEASE CATALYTIC DOMAIN Article Open access 16 September 2022 CRYO-EM STRUCTURES OF HUMAN
A2ML1 ELUCIDATE THE PROTEASE-INHIBITORY MECHANISM OF THE A2M FAMILY Article Open access 31 May 2022 ALLOSTERY IN HOMODIMERIC SARS-COV-2 MAIN PROTEASE Article Open access 04 November 2024
REFERENCES * Ratner, L. _et al_. Complete nucleotide sequence of the AIDS virus, HTLV-III. _Nature_ 313, 277–284 (1985). CAS Google Scholar * Oroszlan, S. in _Viral Proteinases as Targets
For Chemotherapy_ (Eds H. Kräusslich, S. Oroszlan, E. Wimmer) 87–100 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989). Google Scholar * McQuade, T.J. _et al_. A synthetic
HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. _Science_ 247, 454–456 (1990). Article CAS Google Scholar * Huff, J.R. HIV protease: a novel
chemotherapeutic target for AIDS. _J. Med. Chem._ 34, 2305–2314 (1991). Article CAS Google Scholar * Cohen, J. Results on new AIDS drugs bring cautious optimism. _Science._ 271, 755–756
(1996). Article CAS Google Scholar * FDA Press Release (♯95–10), 7 December (1995); and, (♯96–4), 1 March (1996). * Rose, R.E. _et al_. Human immunodeficiency virus type 1 viral
background plays a major role in development of resistance to proteinase inhibitors. _Proc. Natl. Acad. Sci. USA_ 93, 1648–1653 (1996). Article CAS Google Scholar * Condra, J.H. _et al_.
_In vivo_ emergence of HIV-1 variants resistant to multiple protease inhibitors. _Nature_ 374, 569–571 (1995). Article CAS Google Scholar * Hartsuck, J.A. & Tang, J. The carboxylate
ion in the active center of pepsin. _J. Biol. Chem._ 247, 2575–2580 (1972). CAS PubMed Google Scholar * Pearl, L.H. & Taylor, W.R. A structural model for the retroviral proteases.
_Nature_ 329, 351–354 (1987). Article CAS Google Scholar * Pretsch, E., Clerc, T., Seibl, J. & Simon, W. _Spectral Data for Structure Determination of Organic Compounds_
(Springer-Verlag, Berlin, 1989). Book Google Scholar * Holladay, M.W., Salituro, F.G. & Rich, D.H. Synthetic and enzyme inhibition studies of pepstatin analogues containing
hydroxyethylene and ketomethylene dipeptide isosteres. _J. Med. Chem._ 30, 374–383 (1987). Article CAS Google Scholar * Toth, M.V. & Marshall, G.R. A simple, continuous fluorometric
assay for HIV protease. _Int. J. Pept. Protein. Res._ 36, 544–550 (1990). Article CAS Google Scholar * Hyland, L.J., Tomaszek, T.A. & Meek, T.D. Human immunodeficiency virus-1
protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. _Biochemistry_ 30, 8454–8463 (1991). Article CAS Google Scholar *
Furfine, E.S. _et al_. Two-step binding mechanism for HIV protease inhibitors. _Biochemistry_ 31, 7886–7891 (1992). Article CAS Google Scholar * Yamazaki, T. _et al_. NMR and X-ray
evidence that the HIV protease catalytic aspartyl groups are protonated in the complex formed by the protease and a non-peptide cyclic urea-based inhibitor. _J. Amer. Chem. Soc._ 116,
10791–10792 (1994). Article CAS Google Scholar * Fitzgerald, P.M.D. _et al_. Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and
acetyl-pepstatin at 2.0-Å resolution. _J. Biol. Chem._ 265, 14209–14219 (1990). CAS PubMed Google Scholar * McDaniel, D.H. & Brown, H.C. Hydrogen bonding as a factor in the ionization
of dicarboxylic acids. _Science_ 118, 370–374 (1953). Article CAS Google Scholar * Frey, P.A., Whitt, S.A. & Tobin, J.B. A low-barrier hydrogen bond in the catalytic triad of serine
proteinases. _Science_ 264, 1927–1930 (1994). Article CAS Google Scholar * Marciniszyn, J.A., Hartsuck, J.A. & Tang, J.J. Mode of inhibition of acid proteases by pepstatin. _J. Biol.
Chem._ 251, 7088–7094 (1976). CAS PubMed Google Scholar * Marshall, G.R. Structure-activity relations of antagonists of the reninangiotensin system. _Fed. Proc._ 35, 2494–2501 (1976). CAS
PubMed Google Scholar * Suguna, K., Padlan, E.A., Smith, C.W., Carlson, W.D. & Davies, D.R. Binding of a reduced bond peptide inhibitor to the aspartic proteinase from _rhizopus
chinesis_: implications for a mechanism of action. _Proc. Natl. Acad. Sci. USA_ 84, 7009–7013 (1987). Article CAS Google Scholar * Schnölzer, M. & Kent, S.B.H. Constructing proteins
by dovetailing unprotected synthetic peptides: backbone-engineered HIV protease. _Science_ 256, 221–225 (1992). Article Google Scholar * Tóth, G. & Penke, B. An improved method for the
preparation of omega-cyclohexyl esters of aspartic and glutamic acid. _Synthesis_ 361–362 (1992). Article Google Scholar * Schnölzer, M., Alewood, P., Jones, A., Alewood, D. & Kent,
S.B.H. _In situ_ neutralization in Boc-chemistry sol id phase peptide synthesis: rapid, high yield assembly of difficult sequences. _Int. J. Pept. Protein Res._ 40, 180–193 (1992). Article
Google Scholar * Grant, S.K. _et al_. Use of protein folding studies to determine the conformational and dimer stabilities of HIV-1 and SIV proteases. _Biochemistry_ 31, 9491–9501 (1992).
Article CAS Google Scholar * Wlodawer, A. _et al_. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. _Science_ 245, 616–621 (1989). Article CAS
Google Scholar * Mildner, A.M. _et al_. The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.
_Biochemistry_ 33, 9405–9413 (1994). Article CAS Google Scholar * Bergman, D.A. _et al_. Kinetic properties of HIV-1 protease produced by total chemical synthesis with cysteine residues
replaced by isosteric L-α-_n_-butyric acid. _Lett. Pept. Sci._ 2, 99–107 (1995). Article CAS Google Scholar Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of
Biochemistry, University of Queensland, Qld, 4072, Australia Ross Smith * Center for Magnetic Resonance, University of Queensland, Qld, 4072, Australia Ian M. Brereton * The Scripps
Research Institute, La Jolla, California, 92037, USA Richard Y. Chai & Stephen B.H. Kent Authors * Ross Smith View author publications You can also search for this author inPubMed Google
Scholar * Ian M. Brereton View author publications You can also search for this author inPubMed Google Scholar * Richard Y. Chai View author publications You can also search for this author
inPubMed Google Scholar * Stephen B.H. Kent View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS
ARTICLE CITE THIS ARTICLE Smith, R., Brereton, I., Chai, R. _et al._ Ionization states of the catalytic residues in HIV-1 protease. _Nat Struct Mol Biol_ 3, 946–950 (1996).
https://doi.org/10.1038/nsb1196-946 Download citation * Received: 20 May 1996 * Accepted: 20 September 1996 * Issue Date: 01 November 1996 * DOI: https://doi.org/10.1038/nsb1196-946 SHARE
THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to
clipboard Provided by the Springer Nature SharedIt content-sharing initiative